Silence Therapeutics reported -22537000 in Operating Profit for its fiscal quarter ending in September of 2024.


Operating Profit Change Date
AstraZeneca USD 3.51B 166M Jun/2025
Autolus Therapeutics Ltd -82608000 17.37M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Novartis USD 4.86B 201M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Silence Therapeutics -22537000 4.21M Sep/2024